https://nl.marketscreener.com/koers/aandeel/ARS-PHARMACEUTICALS-INC-116155892/nieuws/Ars-Pharmaceuticals-Inc-Kondigt-klinische-studie-met-eenmalige-en-herhaalde-doses-van-neffy-epine-45003529/?utm_source=telegram&utm_medium=social&utm_campaign=share